000			02044 a2200685 4500
005			20250518100545.0
264		0	_c20200429
008			202004s 0 0 eng d
022			_a2284-0729
024	7		_a10.26355/eurrev_202004_20875 _2doi
040			_aNLM _beng _cNLM
100	1		_aDiurno, F
245	0	0	_aEculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. _h[electronic resource]
260			_bEuropean review for medical and pharmacological sciences _c04 2020
300			_a4040-4047 p. _bdigital
500			_aPublication Type: Journal Article; Comment
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aBetacoronavirus
650	0	4	_aCOVID-19
650	0	4	_aComplement Activation
650	0	4	_aCoronavirus
650	0	4	_aCoronavirus Infections
650	0	4	_aHumans
650	0	4	_aPandemics
650	0	4	_aPneumonia, Viral
650	0	4	_aSARS-CoV-2
650	0	4	_aSevere Acute Respiratory Syndrome
700	1		_aNumis, F G
700	1		_aPorta, G
700	1		_aCirillo, F
700	1		_aMaddaluno, S
700	1		_aRagozzino, A
700	1		_aDe Negri, P
700	1		_aDi Gennaro, C
700	1		_aPagano, A
700	1		_aAllegorico, E
700	1		_aBressy, L
700	1		_aBosso, G
700	1		_aFerrara, A
700	1		_aSerra, C
700	1		_aMontisci, A
700	1		_aD'Amico, M
700	1		_aSchiano Lo Morello, S
700	1		_aDi Costanzo, G
700	1		_aTucci, A G
700	1		_aMarchetti, P
700	1		_aDi Vincenzo, U
700	1		_aSorrentino, I
700	1		_aCasciotta, A
700	1		_aFusco, M
700	1		_aBuonerba, C
700	1		_aBerretta, M
700	1		_aCeccarelli, M
700	1		_aNunnari, G
700	1		_aDiessa, Y
700	1		_aCicala, S
700	1		_aFacchini, G
773	0		_tEuropean review for medical and pharmacological sciences _gvol. 24 _gno. 7 _gp. 4040-4047
856	4	0	_uhttps://doi.org/10.26355/eurrev_202004_20875 _zAvailable from publisher's website
999			_c30896211 _d30896211